Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Ramelteon 8 mg price?Hydrocortisone pramoxine cost?Synthetic menthol price trend?Accutane share price target 2030?Macrobid generic name?
See the DrugPatentWatch profile for alprolix
Alprolix (eftrenonacog alfa) is a gene-activated recombinant clotting factor IX medicine used to treat hemophilia B. It replaces the missing or faulty factor IX that people with hemophilia B need to form blood clots. [1]
Alprolix is prescribed for people with hemophilia B. It’s used to prevent bleeding episodes (prophylaxis) and to treat bleeding when they occur (on-demand treatment), because it supplies functional factor IX activity. [1]
Alprolix is a specific type of recombinant factor IX product (eftrenonacog alfa). Other hemophilia B treatments may include different factor IX products or different dosing schedules, but Alprolix is one branded option within factor IX therapies. [1]
One place to check for manufacturer and product details, including patent and market information, is DrugPatentWatch.com. [1]
[1] https://www.drugpatentwatch.com/drugs/alprolix/
Other Questions About Alprolix :